Geptanolimab Uses, Dosage, Side Effects and more
Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).
| Trade Name | Geptanolimab |
| Generic | Geptanolimab |
| Geptanolimab Other Names | Genolimzumab, Geptanolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
